New Developments in Insomnia Medications of Relevance to Mental Health Disorders

被引:9
|
作者
Krystal, Andrew D. [1 ]
机构
[1] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC 27705 USA
关键词
Personalization; Insomnia; Comorbid psychiatric disorders; Suvorexant; Doxepin; Prazosin; Eszopiclone; POSTTRAUMATIC-STRESS-DISORDER; DOXEPIN; MG; GENERALIZED ANXIETY DISORDER; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; COMBAT VETERANS; SLEEP DISTURBANCE; TRAUMA NIGHTMARES; EFFICACY; SAFETY;
D O I
10.1016/j.psc.2015.08.001
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Many insomnia medications with high specificity have become available recently. They provide a window into the clinical effects of modulating specific brain systems and establish a new guiding principal for conceptualizing insomnia medications: "mechanism matters." A new paradigm for insomnia therapy in which specific drugs are selected to target the specific type of sleep difficulty for each patient includes administering specific treatments for patients with insomnia comorbid with particular psychiatric disorders. This article reviews insomnia medications and discusses the implications for optimizing the treatment of insomnia occurring comorbid with psychiatric conditions.
引用
收藏
页码:843 / +
页数:19
相关论文
共 50 条
  • [41] Sleep as a public health concern: insomnia and mental health
    Robotham, Dan
    JOURNAL OF PUBLIC MENTAL HEALTH, 2011, 10 (04) : 234 - 237
  • [42] MENTAL HEALTH DEVELOPMENTS IN ONTARIO
    HENDERSON, HW
    CANADAS MENTAL HEALTH, 1971, 19 (3-4) : 7 - 10
  • [43] MENTAL HEALTH DEVELOPMENTS IN SASKATCHEWAN
    SMITH, CM
    CANADAS MENTAL HEALTH, 1970, 18 (05) : 15 - 20
  • [44] MENTAL HEALTH DEVELOPMENTS IN ONTARIO
    HENDERSON, HW
    CANADAS MENTAL HEALTH, 1971, 19 (02) : 13 - 16
  • [45] Insomnia and mental disorders: data from primary care
    Peceliuniene, J.
    Bunevicius, A.
    Kasiulevicius, V.
    Mickuviene, N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 218 - 218
  • [46] The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management
    Montejo, Angel L.
    Montejo, Laura
    Baldwin, David S.
    WORLD PSYCHIATRY, 2018, 17 (01) : 3 - 11
  • [47] Prescription Patterns of Psychotropic Medications for the Treatment of Psychotic Disorders in the Largest Mental Health Institutions of Uganda
    Rukat, Annika
    Musisi, Seggane
    Stroehle, Andreas
    Mundt, Adrian P.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (05) : 571 - 576
  • [48] Identifying indicators of potentially hazardous prescribing related to mental health disorders and medications: A systematic review
    Khawagi, W.
    Steinke, D.
    Nguyen, J.
    Keers, R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 5 - 5
  • [49] Identifying potential prescribing safety indicators related to mental health disorders and medications: A systematic review
    Khawagi, Wael Y.
    Steinke, Douglas T.
    Nguyen, Joanne
    Keers, Richard N.
    PLOS ONE, 2019, 14 (05):
  • [50] Mental health disorders
    T. T. H. Tu
    Y. Abiko
    A. Toyofuku
    British Dental Journal, 2019, 227 : 1010 - 1010